$SCYX
SCYNEXIS Inc Stock $scyx

$scyx Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-Q Financial Statement

#000117825315000055 Filed on May 15, 2015

Income Statement

Concept	2015 Q1	2014 Q4	2014 Q1
Revenue	$65.00K	$1.060M	$65.00K
YoY Change	0.0%	-71.12%	-98.65%
Cost Of Revenue	$3.231M		$3.960M
YoY Change	-18.41%		-4.58%
Gross Profit	$66.00K		$745.0K
YoY Change	-91.14%		14.62%
Gross Profit Margin	101.54%		1146.15%
Selling, General & Admin	$2.210M	$2.030M	$1.206M
YoY Change	83.25%	65.04%	10.64%
% of Gross Profit	3348.48%		161.88%
Research & Development	$3.787M	$2.670M	$1.320M
YoY Change	186.89%	130.17%	14.78%
% of Gross Profit	5737.88%		177.18%
Depreciation & Amortization	$323.0K	$320.0K	$308.0K
YoY Change	4.87%		-12.0%
% of Gross Profit	489.39%		41.34%
Operating Expenses	$5.997M	$4.700M	$2.526M
YoY Change	137.41%	95.83%	12.77%
Operating Profit	-$5.932M		-$2.461M
YoY Change	141.04%		54.78%
Interest Expense	$1.000K	$0.00	-$44.00K
YoY Change	-102.27%	-100.0%	-95.56%
% of Operating Profit
Other Income/Expense, Net	$1.000K	$0.00	$2.193M
YoY Change	-99.95%
Pretax Income	-$5.931M	-$3.640M	-$268.0K
YoY Change	2113.06%	-83.25%	-87.05%
Income Tax	$0.00	-$260.0K	-$313.0K
% Of Pretax Income
Net Earnings	-$6.384M	-$3.080M	$412.0K
YoY Change	-1649.51%	-85.83%	-119.9%
Net Earnings / Revenue	-9821.54%	-290.57%	633.85%
Basic Earnings Per Share	-$0.75		-$3.65
Diluted Earnings Per Share	-$0.75	-$3.624M	-$6.57
COMMON SHARES
Basic Shares Outstanding	8.516M shares	8.512M shares	334.1K shares
Diluted Shares Outstanding	8.516M shares		609.1K shares

Balance Sheet

Concept	2015 Q1	2014 Q4	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$27.60M	$32.20M	$700.0K
YoY Change	3842.86%
Cash & Equivalents	$27.62M	$32.24M	$650.0K
Short-Term Investments
Other Short-Term Assets	$420.0K	$3.000K	$700.0K
YoY Change	-40.0%	-40.0%
Inventory
Prepaid Expenses
Receivables	$681.0K	$1.118M	$900.0K
Other Receivables	$0.00		$0.00
Total Short-Term Assets	$34.57M	$39.65M	$2.300M
YoY Change	1402.96%	369.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$0.00	$0.00	$5.300M
YoY Change	-100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$32.00K	$25.00K	$5.400M
YoY Change	-99.41%	0.0%
Total Long-Term Assets	$289.0K	$25.00K	$10.70M
YoY Change	-97.3%	-99.37%
TOTAL ASSETS
Total Short-Term Assets	$34.57M	$39.65M	$2.300M
Total Long-Term Assets	$289.0K	$25.00K	$10.70M
Total Assets	$34.86M	$39.67M	$13.00M
YoY Change	168.13%	220.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$903.0K	$426.0K	$2.700M
YoY Change	-66.56%	-71.99%
Accrued Expenses	$3.060M	$2.245M	$1.600M
YoY Change	91.25%	206.69%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$15.00M
YoY Change		-100.0%
Total Short-Term Liabilities	$6.591M	$5.348M	$20.50M
YoY Change	-67.85%	-73.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.300M	$900.0K	$12.90M
YoY Change	-82.17%
Total Long-Term Liabilities	$2.300M	$900.0K	$12.90M
YoY Change	-82.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.591M	$5.348M	$20.50M
Total Long-Term Liabilities	$2.300M	$900.0K	$12.90M
Total Liabilities	$7.419M	$6.241M	$33.40M
YoY Change	-77.79%	-81.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$123.9M	-$117.5M
YoY Change		3.74%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$27.44M	$33.43M	-$20.40M
YoY Change
Total Liabilities & Shareholders Equity	$34.86M	$39.67M	$13.00M
YoY Change	168.13%	220.27%

Cashflow Statement

Concept	2015 Q1	2014 Q4	2014 Q1
OPERATING ACTIVITIES
Net Income	-$6.384M	-$3.080M	$412.0K
YoY Change	-1649.51%	-85.83%	-119.9%
Depreciation, Depletion And Amortization	$323.0K	$320.0K	$308.0K
YoY Change	4.87%		-12.0%
Cash From Operating Activities	-$4.547M	-$1.720M	$3.140M
YoY Change	-244.81%		-269.73%
INVESTING ACTIVITIES
Capital Expenditures	$171.0K	-$70.00K	$74.00K
YoY Change	131.08%		-127.41%
Acquisitions
YoY Change
Other Investing Activities		$0.00	-$990.0K
YoY Change			-294.12%
Cash From Investing Activities	-$171.0K	-$70.00K	-$690.0K
YoY Change	-75.22%		-376.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$95.00K	0.000	-1.740M
YoY Change	-105.46%
NET CHANGE
Cash From Operating Activities	-$4.547M	-1.720M	3.140M
Cash From Investing Activities	-$171.0K	-70.00K	-690.0K
Cash From Financing Activities	$95.00K	0.000	-1.740M
Net Change In Cash	-$4.623M	-1.790M	710.0K
YoY Change	-751.13%		-144.38%
FREE CASH FLOW
Cash From Operating Activities	-$4.547M	-$1.720M	$3.140M
Capital Expenditures	$171.0K	-$70.00K	$74.00K
Free Cash Flow	-$4.718M	-$1.650M	$3.066M
YoY Change	-253.88%		-294.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001178253
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13903832	shares
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2015Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	1999-11-04
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	SCYNEXIS INC
CY2015Q1	scyx	Additional Milestone Payments Maximum AdditionalMilestonePaymentsMaximum	2300000	USD
CY2014Q2	scyx	Adjustmentto Additional Paidin Capital Reclassificationof Warrant Derivative Liability AdjustmenttoAdditionalPaidinCapitalReclassificationofWarrantDerivativeLiability	2701000	USD
CY2014Q1	scyx	Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock	909000	USD
CY2015Q1	scyx	Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock	0	USD
CY2014Q1	scyx	Deemed Dividend For Antidilution Adjustments To Convertible Preferred Stock DeemedDividendForAntidilutionAdjustmentsToConvertiblePreferredStock	214000	USD
CY2015Q1	scyx	Deemed Dividend For Antidilution Adjustments To Convertible Preferred Stock DeemedDividendForAntidilutionAdjustmentsToConvertiblePreferredStock	0	USD
CY2014Q1	scyx	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	1715000	USD
CY2015Q1	scyx	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	257000	USD
CY2012Q3	scyx	Deferred Revenue Recognition Period DeferredRevenueRecognitionPeriod	P6M
CY2013Q3	scyx	Deferred Revenue Recognition Period DeferredRevenueRecognitionPeriod	P70M
CY2014Q1	scyx	Deferred Revenue Recognition Period DeferredRevenueRecognitionPeriod	P48M
CY2014Q1	scyx	Derivative Fair Value Gain Loss From Mark To Market Adjustment DerivativeFairValueGainLossFromMarkToMarketAdjustment	-3145000	USD
CY2014Q1	scyx	Excess Of Fair Value Warrants Over Proceeds ExcessOfFairValueWarrantsOverProceeds	362000	USD
CY2014Q1	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-15000	USD
CY2015Q1	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-57000	USD
CY2014Q1	scyx	Ipo Gross Proceeds Threshold That Triggers Automatic Conversion Of Preferred Stock IpoGrossProceedsThresholdThatTriggersAutomaticConversionOfPreferredStock	20000000	USD
CY2014Q2	scyx	Issuance Of Common Stock Pursuant To Conversion Of Warrants Shares IssuanceOfCommonStockPursuantToConversionOfWarrantsShares	275687	shares
CY2014Q2	scyx	Issuance Of Common Stock Pursuant To Conversion Of Warrants Shares IssuanceOfCommonStockPursuantToConversionOfWarrantsShares	275687	shares
CY2014Q1	scyx	Issuanceof Warrantswith Preferred Stock IssuanceofWarrantswithPreferredStock	544000	USD
CY2015Q1	scyx	Issuanceof Warrantswith Preferred Stock IssuanceofWarrantswithPreferredStock	0	USD
CY2015Q1	scyx	Lease Expiration Extension Date Under Option LeaseExpirationExtensionDateUnderOption	2024-03-31
CY2015Q1	scyx	Lease Expiration Year LeaseExpirationYear	2019
CY2015Q1	scyx	Milestone Payments MilestonePayments	19000000	USD
CY2015Q1	scyx	Number Of License Agreements NumberOfLicenseAgreements	2	Agreement
CY2014Q2	scyx	Offering Expenses OfferingExpenses	4127000	USD
CY2014Q1	scyx	Property And Equipment Purchases In Accounts Payable PropertyAndEquipmentPurchasesInAccountsPayable	204000	USD
CY2015Q1	scyx	Property And Equipment Purchases In Accounts Payable PropertyAndEquipmentPurchasesInAccountsPayable	25000	USD
CY2014Q2	scyx	Researchand Development Arrangement Contractto Performfor Others Period After Notice Required Before Contract Termination ResearchandDevelopmentArrangementContracttoPerformforOthersPeriodAfterNoticeRequiredBeforeContractTermination	P30D
CY2014Q1	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	1320000	USD
CY2015Q1	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	4412000	USD
CY2014Q1	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	0	USD
CY2015Q1	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	194000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	855000	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1372000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1118000	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	681000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2497000	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3280000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17285000	USD
CY2015Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17608000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	150934000	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	151325000	USD
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	110000	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	296000	USD
CY2014Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	536000	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2014Q4	us-gaap	Assets Assets	39672000	USD
CY2015Q1	us-gaap	Assets Assets	34857000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	34736000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	29830000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1402000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	650000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32243000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27620000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-752000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4623000	USD
CY2014Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.20
CY2014Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	14033	shares
CY2015Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	14033	shares
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	847711	shares
CY2015Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1652499	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8512103	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8527210	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8512103	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8527210	shares
CY2014Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	8000	USD
CY2015Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	8000	USD
CY2014Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1691884	shares
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	3960000	USD
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	3231000	USD
CY2014Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	USD
CY2015Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	257000	USD
CY2014Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1294000	USD
CY2015Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1237000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	449000	USD
CY2015Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	480000	USD
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1146000	USD
CY2015Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1050000	USD
CY2014Q1	us-gaap	Depreciation Depreciation	308000	USD
CY2015Q1	us-gaap	Depreciation Depreciation	323000	USD
CY2013Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	12200000	USD
CY2014Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	9998000	USD
CY2014Q1	us-gaap	Dilutive Securities DilutiveSecurities	-2783000	USD
CY2015Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.65
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.75
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.57
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.75
CY2014Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2015Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2014Q2	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	3290000	USD
CY2014Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2783000	USD
CY2015Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	544000	USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	12237000	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	9998000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	745000	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	66000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	635000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1052000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	275000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-448000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1047000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-65000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-186000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	160000	USD
CY2014Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	274988	shares
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2014Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-44000	USD
CY2015Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1000	USD
CY2014Q1	us-gaap	Interest Paid InterestPaid	45000	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	0	USD
CY2014Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	231000	USD
CY2015Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	218000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	6241000	USD
CY2015Q1	us-gaap	Liabilities Liabilities	7419000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	39672000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34857000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3801000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5132000	USD
CY2014Q1	us-gaap	License And Services Revenue LicenseAndServicesRevenue	93000	USD
CY2015Q1	us-gaap	License And Services Revenue LicenseAndServicesRevenue	96000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-839000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	95000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-74000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-171000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	161000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4547000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1221000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6384000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4004000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-6384000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2193000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1000	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	2526000	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	6451000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1781000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6385000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4540000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	291000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1161000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1140000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1122000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	826000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	226000	USD
CY2015Q1	us-gaap	Other Assets Current OtherAssetsCurrent	420000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	101000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	96000	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2014Q1	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	1388000	USD
CY2015Q1	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	0	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	74000	USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	171000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	992000	USD
CY2015Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1157000	USD
CY2014Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	54583000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	544000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	0	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	95000	USD
CY2012Q3	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	313000	USD
CY2013Q3	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	1500000	USD
CY2014Q1	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	500000	USD
CY2015Q1	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	0	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5000	USD
CY2015Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2014Q1	us-gaap	Profit Loss ProfitLoss	412000	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	-6384000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22120000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22282000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4835000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4674000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1320000	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4218000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-117511000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-123895000	USD
CY2014Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1822000	USD
CY2015Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	987000	USD
CY2014Q1	us-gaap	Revenues Revenues	4705000	USD
CY2015Q1	us-gaap	Revenues Revenues	3297000	USD
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	2883000	USD
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	2310000	USD
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1206000	USD
CY2015Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2233000	USD
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	615322	shares
CY2015Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	575416	shares
CY2014Q2	us-gaap	Share Price SharePrice	10.00
CY2015Q1	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	15107	shares
CY2014Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6200000	shares
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	33431000	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	27438000	USD
CY2014Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.25
CY2014Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.196
CY2015Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-4 reverse stock split
CY2014Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	510000	USD
CY2015Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	0	USD
CY2014Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	510000	USD
CY2015Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2014Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	383000	USD
CY2015Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	372000	USD
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	609074	shares
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8516467	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	334086	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8516467	shares
CY2015Q1	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:normal;text-decoration:none;">Revenue Recognition and Deferred Revenue</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company derives the majority of its revenue from providing contract research and development services under fee for service arrangements. The Company also has entered into collaboration arrangements in exchange for non-refundable upfront payments and consideration as services are performed. These arrangements include multiple elements, such as the sale of licenses and the provision of services. Under these arrangements, the Company also is entitled to receive development milestone payments and royalties in the form of a designated percentage of product sales. The Company classifies non-refundable upfront payments, milestone payments and royalties received under collaboration and licensing agreements as revenues within its statements of operations because the Company views such activities as being central to its business operations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Revenue is recognized when all of the following conditions are met: (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been rendered, (iii) fees are fixed or determinable, and (iv) collection of fees is reasonably assured. The Company’s contract research and development services revenue is recognized in the period in which the services are performed. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">When entering into an arrangement, the Company first determines whether the arrangement includes multiple deliverables and is subject to accounting guidance in ASC subtopic 605-25, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:italic;">Multiple-Element Arrangements</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">. If the Company determines that an arrangement includes multiple elements, it determines whether the arrangement should be divided into separate units of accounting and how the arrangement consideration should be measured and allocated among the separate units of accounting. An element qualifies as a separate unit of accounting when the delivered element has standalone value to the customer. The Company’s arrangements do not include a general right of return relative to delivered elements. Any delivered elements that do not qualify as separate units of accounting are combined with other undelivered elements within the arrangement as a single unit of accounting. If the arrangement constitutes a single combined unit of accounting, the Company determines the revenue recognition method for the combined unit of accounting and recognizes the revenue over the period from inception through the date the last deliverable within the single unit of accounting is delivered.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Non-refundable upfront license fees are recorded as deferred revenue and recognized into revenue on a straight-line basis over the estimated period of the Company’s substantive performance obligations. If the Company does not have substantive performance obligations, the Company recognizes non-refundable upfront fees into revenue through the date the deliverable is satisfied. Analyzing the arrangement to identify deliverables requires the use of judgment and each deliverable may be an obligation to deliver services, a right or license to use an asset, or another performance obligation. In arrangements that include license rights and other non-contingent deliverables, such as participation in a steering committee, these deliverables do not have standalone value because the non-contingent deliverables are dependent on the license rights. That is, the non-contingent deliverables would not have value without the license rights, and only the Company can perform the related services. Upfront license rights and non-contingent deliverables, such as participation in a steering committee, do not have standalone value as they are not sold separately and they cannot be resold. In addition, when non-contingent deliverables are sold with upfront license rights, the license rights do not represent the culmination of a separate earnings process. As such, the Company accounts for the license and the non-contingent deliverables as a single combined unit of accounting. In such instances, the license revenue in the form of non-refundable upfront payments is deferred and recognized over the applicable relationship period, which historically has been the estimated period of the Company’s substantive performance obligations or the period the rights granted are in effect. The Company recognizes contingent event-based payments under license agreements when the payments are received. The Company has not received any royalty payments to date.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company will recognize a milestone payment when earned if it is substantive and the Company has </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">no</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> ongoing performance obligations related to the milestone. A milestone payment is considered substantive if it: 1) is commensurate with either the Company’s performance to achieve the milestone or the enhanced value of the delivered item as a result of a specific outcome from the Company’s performance to achieve the milestone; 2) relates solely to past performance; and 3) is reasonable relative to all of the deliverables and payment terms, including other potential milestone consideration, within the arrangement.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Amounts received prior to satisfying all revenue recognition criteria are recorded as deferred revenue in the accompanying balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company’s deferred revenue includes non-refundable upfront payments received under certain licensing and collaboration arrangements that contain substantive performance obligations that the Company is providing over respective defined service or estimated relationship periods. Such non-refundable upfront payments are recognized over these defined service or estimated relationship periods. The Company received non-refundable upfront payments of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$313</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$1,500</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$500</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> in August 2012, August 2013 and January 2014, respectively, which are recognized over periods of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">six</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> months, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">70</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> months and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">48</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> months, respectively. The Company recognized revenue from these upfront payments of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$96</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$93</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">for the three months ended</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">March 31, 2015</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> and 2014, respectively.</font></div></div>

Files In Submission

Name	View Source	Status
0001178253-15-000055-index-headers.html	Edgar Link	pending
0001178253-15-000055-index.html	Edgar Link	pending
0001178253-15-000055.txt	Edgar Link	pending
0001178253-15-000055-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
q12015exhibit311.htm	Edgar Link	pending
q12015exhibit312.htm	Edgar Link	pending
q12015exhibit321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scyx-20150331.xml	Edgar Link	completed
scyx-20150331.xsd	Edgar Link	pending
scyx-20150331x10q.htm	Edgar Link	pending
scyx-20150331_cal.xml	Edgar Link	unprocessable
scyx-20150331_def.xml	Edgar Link	unprocessable
scyx-20150331_lab.xml	Edgar Link	unprocessable
scyx-20150331_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCYX
SCYNEXIS Inc Stock $scyx

2015 Q1 Form 10-Q Financial Statement

#000117825315000055 Filed on May 15, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCYX SCYNEXIS Inc Stock $scyx

2015 Q1 Form 10-Q Financial Statement

#000117825315000055 Filed on May 15, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCYX
SCYNEXIS Inc Stock $scyx